Identification of selected genes associated with the SARS-CoV-2: a therapeutic approach and disease severity
Abstract Background The ongoing pandemic of COVID-19 viruses takes its sole origin from the Wuhan Huanan seafood market, China. The first case was recorded as viral pneumonia and later became a worldwide pandemic (officially declared by WHO on March 11, 2020). Main body SARS-CoV-2 is an extremely in...
Main Authors: | Ramakrishnan Veerabathiran, Barath Ragunath, Vaishak Kaviarasan, Vajagathali Mohammed, Shiek S. S. J. Ahmed |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2021-04-01
|
Series: | Bulletin of the National Research Centre |
Subjects: | |
Online Access: | https://doi.org/10.1186/s42269-021-00540-y |
Similar Items
-
Bioengineered probiotics to control SARS-CoV-2 infection
by: Shantibhusan Senapati, et al.
Published: (2020-05-01) -
SARS-CoV-2 Cellular Entry Is Independent of the ACE2 Cytoplasmic Domain Signaling
by: Thankamani Karthika, et al.
Published: (2021-07-01) -
Human ACE2 Genetic Polymorphism Affecting SARS-CoV and SARS-CoV-2 Entry into Cells
by: Takanari Hattori, et al.
Published: (2022-08-01) -
Importance of ACE2 for SARS-CoV-2 Infection of Kidney Cells
by: Marie-Kristin Kroll, et al.
Published: (2023-03-01) -
Interaction of Human ACE2 to Membrane-Bound SARS-CoV-1 and SARS-CoV-2 S Glycoproteins
by: Sai Priya Anand, et al.
Published: (2020-09-01)